A p38–p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells  by von Brandenstein, Melanie Gerstung et al.
Biochimica et Biophysica Acta 1783 (2008) 1613–1622
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bbamcrA p38–p65 transcription complex induced by endothelin-1 mediates signal
transduction in cancer cells☆
Melanie Gerstung von Brandenstein a,1, Anna Ngum Abety a,1, Reinhard Depping b,2, Tanja Roth a,3,
Matthias Koehler c,4, Hans-Peter Dienes a,5, Jochen W.U. Fries a,⁎
a Institute of Pathology, University Hospital, Kerpernerstraße, 50931 Koeln, Germany
b Institute of Physiology, University Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
c Center for Nephrology and Hypertension, Ostseeklinik and Reha-Klinik Damp, Seute-Deern-Ring 30, 24351 Damp, GermanyAbbreviations: COX-2, cyclooxygenase-2; DMF,
enzyme-linked immunosorbent assay; EMSA, electr
endothelin-1; ET-AR, endothelin A receptor; ET-BR
immunoﬂuorescence; IL, interleukin; MAPK, mitogen-a
N-acetyl cysteine; NF-κB, nuclear factor kappa B; PCR,
quantitative; RT, reverse transcriptase; TNF alpha, tumor
vascular cell adhesion molecule-1
☆ The costs of publication of this article were defrayed
charges. This article must therefore be hereby marked
with 18 U.S.C. Section 1734 solely to indicate this fact.
⁎ Corresponding author. Tel.: +49 221 478 6061; fax:
E-mail addresses: melanie@vonbrandenstein.de (M.G
abety.ngum@smail.bcw.fh-bonn-rhein-sieg.de (A. Ngum
Depping@physio.uni-luebeck.de (R. Depping), tanja.roth
Matthias.koehler@damp.de (M. Koehler), H.P.Dienes@uk
jochen.fries@uni-koeln.de (J.W.U. Fries).
1 Tel.: +49 221 478 3175; fax: +49 221 478 6360.
2 Tel.: +49 451 5004678; fax: +49 451 5004171.
3 Tel.: +49 221 478 5947; fax: +49 221 478 6360.
4 Tel.: +49 453280 8858; fax: +49 435180 8862.
5 Tel.: +49 221 478 5250; fax: +49 221 478 6360.
0167-4889/$ – see front matter © 2008 Elsevier B.V. Al
doi:10.1016/j.bbamcr.2008.04.003A B S T R A C TA R T I C L E I N F OArticle history: Endothelin-1 is a powerful
Received 31 October 2007
Received in revised form 31 March 2008
Accepted 1 April 2008
Available online 16 April 2008
Keywords:
Endothelin-1
MAPK p38
NF-κB
MG 132
Chrysin
Immunoprecipitationmitogen for various tumor and non-tumor cells. Its signaling cascade induces the
inﬂammatory NF-κB complex, leading to expression of a number of target genes. In this context, MAPK p38
has been regarded as a potential phosphate donor for the p65 subunit of NF-κB. In the present study in HeLa
cells, we have found that ET-1 induced signalling activates the NF-κB transcription complex (TC) in the
nucleus at 6 h speciﬁcally via ET-A — but not ET-B receptor. The TC contains p65, p38 (α and β) – binding to
the NLS of p65 in the cytoplasm – as well as p50, but no IκBα. Speciﬁc p38 inhibition by SB203580 or by
siRNA interferes markedly with gene expression of several target genes. Complex formation occurs in the
cytoplasm, and both transcription factors transmigrate as a complex in the nucleus. Overexpression of p38,
treatment with Chrysin, MG132, or dimethylformamide shows dependence of TC on p38 as partner. In other
tumor cells lines studied, ET-1 activates TC, with p38 as an important complex partner of p65. TC-induction
by ET-1 contains about twice the amount of p38 than by TNFα. Thus, p38 may be an additional therapeutic
target to control inﬂammatory gene expression in tumor cells.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
In its physiologically most relevant form, ET-1, ﬁrst described as a
vasoconstrictor peptide [1], has been shown subsequently to be a potent
mitogen invarious tumor cell lines (cervical cancer [2]; breast cancer [3];dimethyl formamide; ELISA,
omobility shift assay; ET-1,
, endothelin-B receptor; IF,
ctivated protein kinase; NAC,
polymerase-chain reaction; q,
necrosis factor alpha; VCAM-1,
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l rights reserved.melanoma[4]; colon cancer [5]; renal cell cancer [6]; prostate cancer [7])
and non-tumor cell lines (interstitial ﬁbroblast [8]; endothelial cells [9];
epithelial cells such as lung [10], as well as pancreas, brain, and kidney
[11]). ET-1 binds via the two independent receptors A and B, the former
mediating cell proliferation, and vasoconstriction, the latter presumably
vasodilatation, natriuresis and ET clearance[12–14]. ET-1 mediated
signal transduction has been linked to the induction of an inﬂammatory
signal transduction cascade via the pleiotropic nuclear factor kappa B
(NF-κB) family of dimeric transcription factors.
The prototypical NF-κB is a p50/p65 heterodimer, while functional
p65 homodimers occur as well [15]. NF-κB is sequestered in the cy-
toplasmby its inhibitor, IκB,which in response to inﬂammatory stimuli
is phosphorylated and targeted for degradation by the proteasome
[16]. Furthermore, phosphorylation of the p65 subunit in one of two
of its transactivation domains [17] has been shown to be essential for
NF-κB transcriptional activation. NF-κB subsequently translocates to
the nucleus and transactivates target genes, that are involved in im-
mune and inﬂammatory responses [16,18].
The p38 mitogen-activated protein kinase pathway has been impli-
cated in the regulation of a wide spectrum of cellular processes, includ-
ing cell-cycle arrest, apoptosis, senescence, regulation of RNA splicing
tumorigenesis and differentiation of various cell types [19–22]. In verte-
brates there are four MAP kinase p38 isoforms, which are all phos-
phorylated andactivatedby theMAPKkinaseMKK6.Onceactivated,p38
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which include transcription factors including NF-κB [23] as well as
protein kinases [22].MAPKp38has also been shown to participate in the
induction of pro-inﬂammatory gene expression through p65 phosphor-
ylation [24,25] in the context of TNFα signaling [17].
In this paper, we show that ET-1 signaling in HeLa cells leads to
speciﬁc NF-κB induction via the ET-A receptor. Thereby, a yet un-
described complex formation between p65 and p38 occurs already in
the cytoplasm, which transmigrates as a complex in the nucleus and
can be detected in nuclear extracts by non-radioactive supershift
EMSAs. Several reagents are able to up- or downregulate (including
siRNA studies) or block the level of p38 and thus the level of gene
expression of a subset of genes, for which this complex formation
proves essential. Immunoprecipitation and subsequent Western
blotting further analyses the components of the complex involved.
In several other tumor cell lines studied inducible by ET-1 via its
speciﬁc receptors, p38 can be shown to be an essential complex
partner for p65. Since the p38 block signiﬁcantly interferes with the
level of gene expression, the present studymay open a newavenue for
a potential therapeutic invention in different tumors.
2. Materials and methods
All reagents used were commercially available at Sigma-Aldrich, except otherwise
speciﬁed.
2.1. Cell lines and treatments
HeLa cells were kindly provided by Dr. A. Pansky, Caki-1 by Prof. Dr. Grünewald,
SK-mel28, 530, MV3 by Prof. Dr. Nischt, and MCF7 by Prof. Dr. Hanisch. All cells were
cultured in Dulbecco's Modiﬁed Eagle Medium (GIBCO) supplemented with 10% FCS
(PAN Laboratories) and 1% Penicillin/Streptomycin (GIBCO) at 37 °C and 5% CO2. For all
experiments, cells were pre-incubated for 24 h with serum-free DMEM. HeLa cells
were grown to 80–90% conﬂuence and treated with endothelin-1 (50 nM, Sigma).
MG132 (10 µM), Chrysin (30 µM) and DMF (35 µM) were used for treatment of HeLa
cells at different time points. For all blocking experiments, reagents were added to
90% conﬂuent HeLa cells 1 h prior to ET-1 treatment. As for speciﬁc p38α andβ inhibitor
SB 203580 (10−6 M) and for p65 inhibition N-acetyl cysteine (NAC, 1 mM) was used.
ET-1-receptor block was achieved using 100 mM either BQ123 (ET-AR antagonist) or
BQ788 (ET-BR antagonist).
2.1.1. Transient transfection
1×106 cells were grown on 6-well plates until they reach a conﬂuence of 50–70%.
For transfection, Fugene HD (Roche) was used according to the manufacturer's protocol.
Cells were harvested 24 h after transfection. The expression plasmid without insert
served as transfection control.
2.2. RNA isolation
RNAwas isolated with the RNeasy kit from Qiagen according to the manufacturer's
protocol. RNA quantiﬁcation was done using the NanoDrop technology.
2.3. RT-PCR
The cDNAwas obtained from 100 ng RNA using random primers and SuperScript II
reverse transcriptase according to the manufacturer's protocol. In order to be in the
semi-quantitative range, the amount of cDNA was previously determined by titration
and the number of PCR cycles was standardized. The PCR reactions were performed in a
ﬁnal volume of 25 µl. For PCR reaction always 2 µl of the RT-PCR product were used and
mixed with RedTaq Ready Mix according to the manufactures protocol. The PCR
reactions were performed with 35 cycles consisting of 0.5–1min at 94 °C, 1 min at 55 °C
annealing temperature,1 min at 72 °C with a ﬁnal extension between 5–10min at 72 °C.
Used primers: ß-actin forward: 5′-TTG GCA ATG AGC GGT TCC GCT G-3, reverse: 5′-TAC
ACG TGT TTG CGG ATG TCC AC-3′, Endothelin-1 forward: 5′-CCA AGGAGC TCC AGA AAC
AG-3′, reverse: 5′GAT GTC CAG GTG GCA GAA GT-3′, IL-6 forward: 5′-GCT ATG AAC TCC
TTC TCC ACA AGC G-3′, reverse: 5′-TGA AGA GGT GAG TGG CTG TC-3′, IL-8 forward: 5′-
TCT TGG CAG CCT TCC TGA TT-3′, reverse: 5′-TCC AGACAGAGC TCT CTT CCA TC-3′, COX-
2 forward: 5′-TGA GCA TCT ACG GTT TGC TG-3′, reverse: 5′-TGC TTG TCT GGA ACA ACT
GC-3′, VCAM forward: 5′-GGC CCA GTT GAA GGA TGC GG-3′, reverse: 5′-GAT TTC TGT
GCT TCT ACA AGA-3′. For analysis of the PCR product 2.5% agarose gels were performed
and were run in 1× TAE buffer.
2.4. siRNA transfection
The siRNA transfection (p38 α and p38 β) was done according to the Santa Cruz
protocol. Best results received with a concentration of 8 µl siRNA duplex and 6 µltransfection reagent. After transfection the cellswere incubated inDMEMand incubated
for 42 h following 6 h treatmentwith ET-150 nMdiluted inDMEM. TheRNA, nuclear and
cytoplasmic extracts were isolated as described. To proof transfection efﬁciency, a PCR
with special Santa Cruz primers was performed according to the protocols provided.
2.5. Site direct mutagenesis
Mutagenesis Kit (Stratagene)was used according to themanufacturer's protocol. For
mutation of the p65 NLS the following primers were used: 5′-CGT CAC CGG ATT GAG
GAGGCAGCT GCA AGGACATAT GAGACC-3′ and 3′-GGT CTC ATATGT CCT TGC AGC TGC
CTC CTC AAT CCGGTGACG-5′. Mutated p65 plasmidwas checked by dideoxy nucleotide
sequence analysis. To proof successful transfectionwithmutated p65 plasmid, a PCRwas
performed with the following conditions: 1 cycle second at 90 °C, followed by 18 cycles
(95 °C for 30 s, 55 °C for 1 min and 68 °C for 2 min).
2.6. Non-radioactive Electrophoretic Mobility Shift Assay (EMSA)
Nuclear extracts were isolated from treated cells and control HeLa according to
the manufactures protocol (Nuclear extraction kit, Active motif). Protein content was
assayed with the Bradford protein assay (Bio-Rad) with BSA as standard. Double
stranded NF-κB oligonucleotides, described previously [26] were commercially
synthesized (Operon Biotechnologies GmbH) and the forward strand was labelled
with Cy5 as published [27]. NF-κB binding reactions were conducted in 200 mM TRIS–
HCL pH 7.6, 50 mM MgCl2, 0.1 mM EDTA and 10 mM DTT. To prepare the DNA for
annealing, the probes (1 pmol each) were incubated at 70 °C for exactly 10 min and a
further 30 min at room temperature. For the protein/DNA binding reaction, 5 µg of
protein were added to the samples and incubated for 30 min on ice. The reaction was
analysed by electrophoresis in a non-denaturation 6% polyacrylamide gel in 1xTBE
buffer. For supershift EMSAs, a phosphorylated p38 (p-p38) antibody against the
subunits of p38α, β, δ (Promega) and a p65 antibody (Santa Cruz) was used. As negative
control, 300× more concentrated non-labelled, “cold” NF-κB probes were incubated
with 5 µg of protein and added to a Cy5 labelled sample. All EMSAs were performed as
triplicates and visualized with a ﬂuorescence reader (FLA-3000, Fujiﬁlm).
2.7. ELISA
Streptavidin-coated 96well plates (Pierce)were incubatedwith a capture biotinylated
p65 antibody (Biomol) for 2 h at RT. The samples werewashed 3×with PBS and incubated
with either 5 µg of the nuclear extracts or 15 µg of the cytoplasmic extracts for 1 h. The
wells were washed 3× with PBS and incubated for a further hour with a phosphorylated
p38 (p-p38) antibody against the subunits of p38 α, β, δ (Promega) and an IкBα antibody
(Santa Cruz). For signal detection a Cy2 labelled anti-rabbit antibody was used and
incubated for a further hour at RT. Finally the ELISAwaswashed 3×with PBS and analysed
with an ELISA top reader (Genios Pro).
ELISA followed by Western blot–Strepdavidin-coated 96 well plates (Pierce) was
incubated with a biotinylated anti-rabbit antibody for 2 h at RT. Meanwhile, 1.0 µg
nuclear or cytoplasmic extract was incubated with an antibody speciﬁc for p38 (α, β, δ)
(Promega) in binding buffer for 1 h on ice. The samples were washed 3× with PBS and
the antibody binding was disruptedwith Glycin-Buffer pH 3.0. For pH neutralization the
samples were treated with equal volume of TRIS–HCL Buffer pH 9.0. The extractmixture
was used for Western blot analysis.
2.8. Immunoprecipitation assay
For immunoprecipitation either a p38 agarose conjugated or a p65 agarose conjugated
antibody (Santa Cruz) was used. The assay was performed according to the Santa Cruz
protocol. 1000 µg total cellular proteinwas used. The ﬁnal washing stepwas done 4×with
PBS and the sampleswere diluted in 15 µl 2× electrophoresis sample buffer. After a boiling
step of 4 min, the samples were centrifuged and used for Western blot analysis.
2.9. Western blot analysis
Nuclear extracts were isolated and the concentration was determined as described
previously. Proteins (15 µg) were separated by 10% SDS-PAGE and transferred to a PVDF
membrane (Carl Roth). Membranes were blocked in 3% TBST-Milk or for the p-p38 (α, β, δ)
(Promega) in 0.1% Casein. Membranes were incubated with speciﬁc antibodies against
phosphorylated p38 (p-p38) against the subunits of p38 α, β, δ (Promega), 1:2000, for 2 h
(Promega), NFκB p65, 1:1000, for 1 h (Santa Cruz), IκBα, 1:1000 for 1 h (Santa Cruz), p38
beta1:1000 for1h (SantaCruz), p501:1000 for 1h (SantaCruz), andp38gamma1:1000 for
1 h (Santa Cruz). The importin antibodieswere diluted 1:5000 and an incubation step over
night was performed [28]. For visualisation a goat anti-rabbit IgG (Santa Cruz) antibody
(1:10,000), rabbit-anti goat IgG antibody (1:10,000) (Jackson) or a goat anti-mouse IgG2a
antibody (1:5000) (Santa Cruz) was employed, conjugated with HRP using enhanced
chemiluminescencePlus reagents (Pierce) according to themanufacturer's instructions and
the highly sensitive Chemiluminescence-Diana III CCD (Bio Imaging) program for analysis.
2.10. Densitometry
For densitometrical analysis the LabImage 1D 2006 programwas used according to
the protocols. Statistics: mean and standard deviation were calculated. Differences
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were considered statistically signiﬁcant.
3. Results
3.1. Analysis of endothelin-1 signaling: EMSAs using nuclear extract and
RT-PCRs
3.1.1. ET-1 induces NF-κB p65 in a time dependent manner via
ET-A receptor
Since it is known that endothelin-1 signaling may involve the p65
member of the nuclear factor kappa B transcription family in other cell
lines, the ﬁrst step in our analysis was the demonstration of a time
dependent p65 induction after stimulation of HeLa cells. A single dose
of 50 nM endothelin-1 (Fig. 1A), results in an induction maximum at
3 to 6 h, returning to constitutive levels of expression after 8 h. In
parallel, the expression of the respective receptors A and B were in-
vestigated. Blocking the ET-A receptor, only at 3 h the transcription
complex (TC) intensity is clearly above background. In contrast,
blocking of the ET-B receptor leads to an increased TC signal above
background in a time dependent fashion with a maximum at 3 to 6 h.
The intensity for the NF-κB signal is slightly higher after ET-B-receptor
block than the one observed after endothelin-1 stimulation via both
receptors.
3.1.2. The endothelin-transcription complex (TC) consists of p65 and
MAPK p38
To further investigate the endothelin-induced transcription com-
plex, an EMSA was performed, using the 6 h stimulation timepoint.
The intensity of the induced TC was clearly reduced when antibodies
against MAPK p38 or p65 were employed, and a supershifted band is
visible (arrow; Fig. 1B).
To prove the speciﬁcity of the binding reaction of the two
components, p65 and p38, an ELISA assay with MAPK p38 antibody
as anchor was followed by Western blot analysis using a anti-p65
antibody for detection. A single band of the expected (about) 65 kDa
was found (Fig. 1C.).
3.1.3. Speciﬁc silencing of p38 α and β RNA results in reduction of NF-κB
activity and target gene expression
To analyse the importance of either transcription factor for the TC,
an siRNA experiment was set up, transfecting either siRNa speciﬁc
against the alpha or the beta component of MAPK p38. As can be seen
in Fig. 1D, the use of either siRNA reduces the strength of the TC to a
level even below that seen in mock-transfected control cells.
To demonstrate the functional effect of siRNA induced suppression
of either MAPK p38 alpha or beta induction, a PCR was performed
using Cox-2, IL-8, IL-6, and ET-1 as target genes. As seen in Fig.1E, gene
expression is greatly reduced after employment of either siRNa, except
for ET-1.
3.1.4. Modiﬁers of p38 and their effect on gene expression
The importance of p38 as a member of the TC was further studied
using 3 different modiﬁers of MAPKp38 levels and their effect on
gene expression as known from the literature. Chrysin is a ﬂavonoid
with the potential to induce p38, and to activate NF-κB/p65 in HeLa
cells (33). HeLa cells were treated for 24 h either with 30 µM of
Chrysin (5,7-dihydroxyﬂavone) dissolved in DMSO or N-acetyl
cysteine (NAC), a p65 inhibitor. Chrysin induced a signiﬁcant signal
for NF-κB versus control by EMSA, which was signiﬁcantly lowered
by SB203580, a speciﬁc inhibitor of p38 α and β, or by NAC pre-
treatment (Fig. 1F).
Treatment with a proteasome inhibitor, MG132, has also been
shown to induce MAPK p38 (33). MG132 was used at 10 µg/ml dis-
solved in DMSO for 24 h. Control cells were incubated with DMEM
containing the same volume of DMSO as in chrysin/MG132 treatedcells and incubated for the same period of time. In MG132 treated
cells, a strong NF-κB/p65 signal was obtained, inhibited by SB203580
or by NAC pre-treatment (Fig. 1F).
Finally, dimethylfumarate (DMF), a fumaric acid derivative, was
used, since it has been shown to inhibit TNFα-induced nuclear entry
of NF-κB/p65 in endothelial cells [37]. To that end cells were treated
with either 70 µM or 35 µM dimethylfumarate (DMF) dissolved in
methanol for 1, 3, 6,12 and 24 h. Control cells received the same volume
of methanol as in DMF treated cells. Widespread cell death was
observed at DMF concentration of 70 µM, and at 35 µM beyond 6 h
of incubation. While no effect was seen at the 1 h timepoint, NF-κB
activity was downregulated beginning at 3 h. and with a maximal
effect at 6 h, including the level of supershifted, phosphorylated p38 α
(data not shown).
To demonstrate the functional effect of those modiﬁers, Fig. 1G
displays results from PCR analyses, showing downregulation of
several target genes, normally upregulated after ET-1 stimulation of
HeLa cells. Furthermore, pre-treatment with a speciﬁc p38 blocker,
SB203580, markedly reduced ET-1 mediated gene expression levels
(Fig. 1H).
3.1.5.. Analysis of constitutively active NF-κB in HeLa cells
Since a constitutive induction of NF-κB has been described in HeLa
cells, the composition of that complex was investigated by EMSA
(Fig. 1I) using antibodies to p65 and p38. Only for p65, a signiﬁcant
reduction in the TC intensity could be observed.
3.2. Analysis of endothelin-1 signaling: EMSAs using cytoplasmic extract
and RT-PCRs
3.2.1. Cytoplasmic assembly of the p65–p38 components after ET-1
induction
The detection of a nuclear TC containing p65 and p38 raised the
question, whether this complex was already assembling in the
cytoplasm. In a ﬁrst step, the activity of NF-κB in the cytoplasm
after endothelin-1 induction was proven over time (Fig. 2A) with a
maximal detectability at 1 to 3 h. In an EMSA (Fig. 2B), using p65 or
p38 antibodies and cytoplasmic extract, a signiﬁcant reduction in the
induced signal and a weak supershifted band was obtained (arrow). A
supershift was demonstrated in an EMSA experiment after pre-
incubation with either a p38 or p65 antibody by subsequent Western
blotting using a p65 antibody (Fig. 2C.).
To prove binding of the two components, p65 and p38, to each
other in the cytoplasm, an ELISA with a p38 antibody as anchor was
followed by aWestern blot analysis using a p65 antibody for detection
(Fig. 2D). A clear signal was visible after 1 h ET-1 stimulation.
3.2.2. The p65 nuclear location sequence (NLS) is important for p38
binding and gene expression
The nuclear location sequence (NLS) has been shown to be
important for the translocation of a protein from the cytoplasm into
the nucleus but also as binding site for IκB (in non-stimulated cells),
and p38 (in stimulated cells). To prove, whether the NLS has similar
importance in the context of p65–p38 binding, we investigated the
result of endothelin-1 induced transcription after transfection of a p65
expression plasmid with a non-mutated NLS versus one with a
mutated NLS (Fig. 2E). The non-mutated p65 expression plasmid
yields amoderate increase of NF-κB activity over backgroundwith loss
of signal intensity and a weak supershifted band using either a p38 or
a p65 antibody. The mutated p65 expression plasmid yielded a strong
NF-κB signal, reducible by p65 supershift, however, not by p38 super-
shift (EMSA, left panel). The results are supported by densitometric
analysis (Fig. 2E, right panel).
To demonstrate the functional effect of transfection of a p65
expression plasmid without (t.p65) or with mutated NLS (mut. NLS)
vs. an expression plasmid for p38 (t.p38), a PCR assay for several target
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were able to induce the target genes tested, although to different
degrees. However, mutation of the NLS resulted in highly reduced
gene expression levels for Cox-2 and IL-6.Fig. 1. Analysis of endothelin-1 signalling: EMSAs using nuclear extract and RT-PCRs. HeLa c
each EMSA, and a non-radioactively Cy5-labelled-p65 oligonucleotide representing the consens
(α/β/δ) or p65. (A) ET-1 inducesNF-κBp65 ina timedependentmannervia ET-A receptor. Toppa
induction. Results of NF-κB activity after blocking ET-A receptor (middle panel) or ET-B receptor
increase inB-receptor levels abovebackgroundwasobservedbeingmaximal at3 h.Blocking the
at 3 to 6 h vs. control, remaining above background levels up to 24 h. The endothelin-transcriptio
transcription factor leads to a reducedNF-κB signal and aweakly supershifted band. (C) An ELISA
(recognizing all three p38 isoforms,α/β/δ) coated plate. The bound complexwas detached, load
using a p65 antibody. Speciﬁc silencingof p38α and β RNA results in reduction of NF-κB activity
8 μl of speciﬁc siRNA against p38α or p38 β, respectively. Fig.1E. Target gene expression is signi
siRNA transfection,using reversely transcribedRNAandgene speciﬁcprimers following35 round
onlymarginally reduced.β-actin serves as ampliﬁcationcontrol.Modiﬁers of p38 and theireffect
MG132 induces a high NF-κB activity as seen by EMSA, which can be suppressed using either 10
cysteine (NAC) for 1 h. (G) Effect of p38modiﬁers on gene expression by RT-PCR. Both, Chrysin a
as ampliﬁcation control. (H) SB203580 has a strong reducing effect on target gene expression l
ampliﬁcation control. (I) Analysis of constitutively active NF-κB inHeLa cells. NF-κB signal by EM
signiﬁcant changes are obtained in the signal intensity using a p-p38 (α/β/δ) antibody comparTo investigate the binding behaviour of IΚB versus p38 in non-
stimulated versus ET-1 stimulated HeLa cells, an ELISA assay was
performed using cytoplasmic extract and p65 as capture antibody
(Fig. 2G). At 6 h after induction, levels of IκB strongly decreaseells were stimulated with 50 nM endothelin-1 (ET-1), using 5 µg of nuclear extracts for
usNF-κB site. Supershift analyseswere performedwith antibodies speciﬁc for either p-p38
nel: timecourseofNF-κBactivity vs. control demonstrateshighest signal at 3–6hafter ET-1
(lowest panel) with 100 nMof each receptor antagonist. After ET-A-receptor block, a slight
ET-B receptor results inhighNF-κBactivity ina timedependentmannerwithhighest values
n complex (TC) consists of p65 andMAPK p38. (B) EMSAwith supershift analysis for either
was performed addingHeLa nuclear extract after 6 h ET-1 stimulation to a p-p38 antibody
ed on a denaturing gel followed byWestern blot analysis. A signal of about 65 kDa is visible
and target gene expression. (D) EMSA: ET-1 inducedNF-κB signal can be suppressed using
ﬁcantly reduced for Cox-2, IL-8, and Il-6 as shown by RT-PCR after p38α and p38 β speciﬁc
s of ampliﬁcation, compared toET-1 inducedgene levels. Levels of ET-1geneexpressionare
ongene expression. (F) TreatmentofHeLa cells for 1 hwitheither30 μMChrysin and10 μM
–6 M of the speciﬁc p38α and β inhibitor SB203580 or 1mM of the p65 inhibitorN-acetyl
ndMG132 induce higher gene expression levels than ET-1 stimulation alone.β-actin serves
evels by RT-PCR in comparison to ET-1 stimulation for all genes studied. β-actin serves as
SA in untreated, normalHeLa cells can be supershiftedwith a p65 antibody. In contrast, no
ed to control.
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restricted, moderate increase.
3.3. Components of the endothelin-1 induced transcription complex
Since different transcription factors have been reported in the
literature as potential partners of the NF-κB complex, an immuno-
precipitation was performed followed by Western blotting to detectFig. 2. Analysis of endothelin-1 signalling: EMSAs using cytoplasmic extract and RT-PCRs. Cyt
the activity of NF-κB in the cytoplasm after endothelin-1 induction by EMSA demonstrates up
EMSA, using a p65 or p-p38 (α/β/δ) antibody and cytoplasmic extract, a signiﬁcant reducti
(C) Results of an EMSAblotted onto PVDFmembrane and subsequently incubatedwith a p-p65
p-p38 (α/β/δ) or p65 antibody. (D) To prove binding of the two components, p65 and p38, to ea
was used to coat an ELISA plate as anchor, and was incubated with cytoplasmic extract from E
loaded on a denaturing gel followed byWestern blot analysis using a p65 antibody for detectio
location sequence (NLS) is important for p38 binding and gene expression. (E) The importance
mutated p65 expression plasmid after 24 h of transfection in HeLa cells. Left panel: A mode
expression plasmid over background, which can be (weakly) supershifted with either a p-p38
signal, reducible by p65 but not by p38 supershift. Right panel: Densitometry of the induce
expression plasmid withmutated NLS versus that with additional p38 supershift analysis. In c
additional p65 supershift is statistically signiﬁcant (pb0.01). (F) By RT-PCR, using RNA fromH
(mut. NLS) or an expression plasmid for p38 (t.p38), gene expression levels of different target
Cox-2 and IL-6, with ET-1 to a lesser degree. In contrast, p38 induces predominantly ET-1 a
(Mut. NLS) reduced gene expression levels strongly for Cox-2 and IL-6, but not signiﬁcantly for
HeLa cells either after 3, 6 or 24hof ET-1 stimulation or left untreated, the amount of IκB vs. p3
while at the same time point p38 levels show a time-restricted, moderate increase.and characterize the binding partners of p65 after endothelin-1
stimulation in HeLa cells. In the initial experiment, immunoprecipita-
tion with a p38 agarose-conjugated (AC) antibody allowed the
detection of increased levels of p65 by Western blot (Fig. 3A).
Subsequently, this settingwas used to analyse other potential partners
in the complex. With p38 antibody as capture antibody, only a small
amount of p50 (Fig. 3B), and no IκBα or p38 gamma (data not shown)
were detected. Furthermore, a weak signal was obtained with aoplasmic assembly of the p65–p38 components after ET-1 induction. (A) Time course of
regulation over control cells from 1 to 24 h with maximal detectability at 1 to 3 h. (B) By
on in the induced NF-κB signal and a supershifted band for p65 (arrow) was obtained.
antibody reveals a supershifted band in ET-1 induced extracts pre-incubatedwith either
ch other in the cytoplasm,MAPKp-p38 antibody detecting all three p38 isoforms (α/β/δ)
T-1 induced HeLa cells. Subsequently, the entire complex attached to p38 was detached,
n. A strong signal of about 65 kDawas visible after 1 h ET-1 stimulation. The p65 nuclear
of the NLS site for the interaction of p65with p38was studied using non-mutated versus
rate increase in NF-κB signal is obtained by after transfection of the non-mutated p65
(α/β/δ) or a p65 antibody. The mutated p65 expression plasmid yielded a strong NF-κB
d signals reveals no difference in signalling intensity between the transfection of p65
ontrast, the difference between p65 expression plasmid withmutated NLS and that with
eLa cells transfectedwith a p65 expression plasmid without (t.p65) or withmutated NLS
genes were analysed. Both expression plasmids induce target genes: p65 predominantly
nd IL-6, and to a lesser degree, Cox-2. Expression plasmid p65 with mutated NLS site
ET-1. (G) In an ELISA assaywith p65 antibody coated plates and cytoplasmic extract from
8bindingwasmeasured. At 6 h after induction, levels of IκB transiently stronglydecrease,
Fig. 3. Components of the endothelin-1 induced transcription complex. (A) Immunopre-
cipitation of HeLa cell extract after ET-1 stimulation or from untreated cells was performed
using a p38 agarose-conjugated (AC) antibody followed byWestern blotting. In the extract
of stimulatedHeLa cells, increased levels of p65 could bedetected. (B) Immunoprecipitation
using either a p38 agarose-conjugated (p38 AC) or p65 agarose-conjugated (p65 AC)
antibody and subsequent Western blotting with speciﬁc antibodies against different
potential NF-κB binding partners. By p38 AC antibody, small amounts of p50 (speciﬁc
antibody), aweak signal for p38 ß (ß speciﬁc antibody) and a stronger onewith a p-p38 (α/
β/δ) antibody were obtained. With p65 AC antibody, only small amounts of p50 and IκBα
(both speciﬁc antibodies) couldbedetected in the control extract. (C)Westernblots done in
parallel from immunoprecipitation experiments in Fig. 3B. were used to analyse binding of
potential importin family members. Importin α4 can be found only in the control p65
precipitate. Importin 5α is seen inp38 and p65 AC antibody immunoprecipitates as aweak
signal from the uninduced control and stronger in the p38 AC antibody immunoprecipitate
from ET-1 stimulated HeLa cells. After TNFα stimulation and p38 AC antibody im-
munoprecipitation, only a small signal can be detected for p38.
Fig. 4. ET-1 induction of NF-κB complex (TC) in various tumor cell lines. Potential
complex formation between p65 and p38was analysed by nuclear extract in an EMSA in
different human tumor cell lines: cervical cancer (HeLa), breast carcinoma (MCF-7),
renal cell carcinoma (Caki-1), and melanoma (non-metastasizing: 530; weakly
metastasizing: Sk-mel28; strongly metastasizing: MV3), known to express the A or B
endothelin receptor at their surface. In all cell lines, pre-treatment for 6 h with ET-1
induced a clear NF-κB signal versus untreated cells. The effect of pre-incubation with a
p65 antibody was small. In contrast, pre-incubation with a p-p38 (α/β/δ) antibody
markedly reduced the NF-κB signal in HeLa, MCF-7, and MV3 cells. The signal reduction
was weak in Caki-1, and Sk-mel28 cells, while no reductionwas found in the melanoma
cell line 530.
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(with speciﬁcity for all three isoforms: α/β/δ).
Since the translocation of the NF-κB complex has been attributed
to members of the importin family, p38 immunoprecipitated cell
extracts after endothelin-1 induction for 1 h or TNF alpha induction for
1 h (as control) have been studied for respective importin binding
partners. As the lower panels of Fig. 3B indicate, importin α4 signal
can be found only in the precipitate of the control extract. An importin
α5 signal can be seen in both lanes with immunoprecipitates from
control extracts and also – induced – in immunoprecipitates from ET-1
stimulated cell extracts but not for immunoprecipitates after TNFα
stimulation.
3.4. ET-1 induction of NF-κB complex (TC) in various tumor cell lines
The complex formation between p65 and p38 after ET-1 induction
was analysed in other tumor cell lines, known to express the A or B
endothelin receptor at their surface. In all cell lines shown, the
expected NF-κB signal was detected in nuclear extracts by EMSA after
ET-1 treatment for 6 h. A supershift analysis with speciﬁc, antibodies
against p65 or p38 reduced the NF-κB signal particularly with anti p38
in all but one cell line studied (Fig. 4).
3.5. Role of p38 in the TC induced by ET-1 versus TNFα
To compare the amount of p38 present in the TC after ET-1
versus TNFα induction, nuclear extracts of HeLa cells after 6 h ofstimulation with either mediator are used, and an EMSA with addi-
tional supershift analysis with antibodies for p65 and p38 is per-
formed. In Fig. 5A, a TC is induced by ET-1, showing the participation
of p65 and p38, with p38 representing about 56% of the complex
densitometrically. This result was analysed in parallel for gene
expression (Fig. 5B). All genes studied were induced (as relative
percent of ß-actin expression). After SB block, a decrease of at least
50% of gene induction was observed. The TC induced by TNFα
contains predominantly p65 and less p38, as shown by supershift
analysis (Fig. 5C), with only 36% represented by p38 densitome-
trically. The results of the respective gene expression analysis by
PCR (Fig. 5D) demonstrate induction of all genes studied. Blocking
p38 reduces levels of gene expression predominantly for ET-1 and
IL-6 with almost no change observed for IL-8 and COX-2. Differences
in the amount of p38 present in the TC between ET-1 and TNFα
were analysed by ELISA assay, using a speciﬁc, capture antibody for
p65 followed by an anti-p38 antibody. Fig. 5E shows that ET-1
induced TC has about twice the amount of p38 than after induction
by TNFα.
4. Discussion
The paper presents evidence for ET-1 induced, inﬂammatory signal
transduction, showing a novel role of MAPK p38 as complex partner of
p65 in the NF-κB transcriptional complex, thereafter referred to as TC.
This observation in HeLa cells expands present knowledge, in which
the role of MAPK p38 is regarded solely as a phosphate donor to p65
[29].
Thus, to investigate this presently unknown role for MAPK p38
after ET-1 stimulation, experimental evidence is gathered on ﬁvemain
aspects: (i) analysis of endothelin-1 signalling by EMSAs using nuclear
extracts and gene expression studies by RT-PCR, (ii) analysis of
endothelin-1 signalling by EMSAs using cytoplasmic extracts and gene
expression studies by RT-PCR, (iii) components of the enodthelin-1
induced transcription complex, (iv) detection of p38 in the TC in other
tumor cell lines, and (vi) the role of p38 in the TC induced by ET-1
versus TNFα and the respective gene expression.
Recently, we have shown, that ET-1 is capable of activating the
inﬂammatory NF-κB signaling cascade via the ET-A receptor in human
proximal tubule epithelial cells [27]. Here, we show in nuclear extracts
from HeLa cells, that ET-1 is equally capable of inducing NF-κB. In
Fig. 5. Role of p38 in the TC induced by ET-1 versus TNFα using nuclear extracts. (A) EMSA showingNF-κB signal induction after 6 h of ET-1 stimulation versus control. Pre-incubation of
the extract showsmarked signal reductionwith the p-p38 (α/β/δ) and the p65 antibody; with the latter a supershifted band is visible. Densitometric analysis reveals that MAPK p38
represent 56%, and p65 only 35%of the TC. (B) Extracting RNA after 6 h of ET-1 treatment, a RT-PCRexperimentwas performedwith speciﬁc primers for differentNF-κB target genes. All
genes analysed are strongly induced by ET-1, (as a relative percent of ß-actin expression). This result can be counteracted using the p-p38 (α/β/δ) speciﬁc inhibitor SB203580: the
reduction of gene expression is overall about 50%, for Il-6 66%. (C). EMSA showing NF-κB signal induction after 6 h of 500 U TNFα stimulation versus control. Pre-incubation of the
extract showsmarked signal reductionwith the p65 antibody and only aminimal effect of the p-p38 (α/β/δ). Densitometric analysis reveals thatMAPK p38 represent only 36% , while
p65 represents 55% of the TC. (D) Extracting RNA after 6 h of TNFα treatment, a RT-PCR experiment was performed with speciﬁc primers for different NF-κB target genes. All genes
analysed are strongly induced by TNFα (as relative percent of ß-actin expression). This result can be only partially counteracted using the p38α and β-speciﬁc inhibitor SB203580: the
reduction of gene expression is about 50% for Et-1 and 70% for Il-5, however, minimal for Il-8 (about 10%), and Cox-2 (about 13%). (E) For quantitative analysis of the difference in p38
content between the TC induced by ET-1 vs. by TNFα an ELISAwas performedwith a p65 antibody coated plate. Thiswas overlaidwith HeLa cell extracts frompre-treated cells (ET-1 vs.
TNFα for 6 h) followed by detection using the p-p38 (α/β/δ) antibody. The calculated amount of p38 in the TC induced by TNFα was about half of that induced by ET-1.
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of NF-κB occurs at 3 to 8 h via the endothelin A receptor (Fig.1A). The B
receptor seems to have a suppressive effect on the NF-κB induction,
and only a slight inducing effect at 3 h.
Unexpectedly, MAPK p38 could be demonstrated as partner of p65
in the formation of NF-κB using nuclear extracts (Fig. 1B). While
supershift analysis with a Cy5, non-radioactively labelled oligonucleo-
tide speciﬁc for the p65 binding site of NF-κB using speciﬁc antibodies
yielded rather weak signals, we demonstrate the speciﬁc binding
between the two transcription factors in nuclear extracts by using a
combination of ELISA and Western blot. Proteins from the nuclear
extracts binding to a phosphorylated p-38 antibody (against three p38
isoforms α/β/δ) coated ELISA plate were harvested and run on a
denaturing gel followed by Western blotting. With this method, a
65 kDa protein could be detected as binding partner using a p65
antibody (Fig. 1C).
To further strengthen the concept of the importance of this
interaction between p38 and p65, the siRNA technology is used.
Subunits of p38 (alpha and beta) can be downregulated following
siRNA transfection so that the ET-1 induced NF-κB signal is suppressed
lower than in the control (Fig. 1D). In addition, the effect of geneexpression was also a marked reduction after siRNA transfection for
both p38 isoforms. Interestingly, levels of ET-1 were only marginally
affected.
In the next set of experiments in Figs. 1F and G, we have
investigated to which degree well characterized mediators of p38
(and in part of p65) will inﬂuence their expression level and that of the
entire TC. We investigated the effect of two mediators of p38
upregulation with different pathophysiologic mechanisms: Chrysin,
and MG132. Chrysin, belongs to a class of dietary polyphenolic
compounds called ﬂavonoids, being able to inhibit the LPS-induced
release of stimulatory cytokines (IL-1β and TNFα) in macrophages
[30]. As an apigenin analogue, it is known as one of the most potent
ﬂavonoids due to its 2 hydroxyl groups [31] and can induce p38
phosphorylation [32]. In agreement with observations of Weng et al.
[32], we found that Chrysin activates NF-κB/p65 in HeLa cells. The
presence of p65 and p38 in the TC can be shown using inhibitors for
either transcription factor (Fig. 1F).
The peptide aldehyde carbobenzoxyl-leucinyl-leucinyl-leucinal-H
(MG132) has been known to inhibit the proteolytic activity of the 20S
and 26S proteasomal complex [33]. In endothelial cells, Read et al. [34]
demonstrated the inhibitory effect of MG132 on cytokine-induced
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treatment, potentially involving MAP-ERK kinases [35]. In HeLa cells,
MG132 can induce MAPK p38 [32], however, the effect is relatively
slow (4 h) compared to LPS (15min). In accordancewith the literature,
we demonstrate a strong p38 upregulation after MG132 pre-
treatment for 24 h, with p38 participating in the newly formed TC
(Fig. 3A). To proof the importance of either mediator versus ET-1
stimulation, a PCR analysis was performed, analysing levels of gene
expression (Fig. 3B). Thus, we investigated the effect of ET-1
stimulation versus up- (Chrysin), and downregulation (SB203580) of
p38 as well as p65 upregulation (MG132) on these target genes. As
could be expected, ET-1 stimulation increased target gene expression.
At least a two fold upregulation was observed using Chrysin, which
activates p38 [32]. Even higher gene expression levels were observed
with MG132, inhibiting the degradation of the p65 inhibitory protein,
IκB, while being able to induce p38.
In contrast, SB23580, a speciﬁc inhibitor for the p38 α and β
isoform, downregulates gene expression levels markedly for all genes
tested (Fig. 1H). Thus, it can be concluded that these p38 and
particularly its two isoforms alpha and beta represent an important
component in the p65–p38 complex.
In HeLa cells, a constitutive NF-κB expression has been described in
the literature. In order to differentiate the response after ET-1
induction from this constitutive expression, an EMSA was performed
(Fig. 1I), which contained the p65 component by supershift but no
detectable p38. Measuring p38 levels should therefore directly reﬂect
the effect of signal transduction.
Since the TC is readily transmigrating into the nucleus, we also
studied the effect of dimethylfumarate, a fumaric acid derivative,
which has been shown to inhibit TNF-induced nuclear entry of
NF-κB/p65 in endothelial cells [36]. Unexpectedly, the dosage used
in endothelial cells proved toxic in HeLa cells, necessitating the
reduction of the dose to 35 μM (about half that of endothelial cells).
Under these conditions, a reduction of detectable nuclear p65 and – by
supershift analysis – of p38 was observed at 6 h. While an extended
temporal analysis was prevented due to cell death in increasing
numbers after 6 h of DMF, the results are in principal agreement with
the effect in endothelial cells [36], blocking nuclear entry of a TC
consisting of p65 and p38.
The second set of experiment is performed in regard to the
question, whether p38 and p65 are attaching to each other already in
the cytoplasm. Using the 1 h time point of ET-1 induced NF-κB signal
(Fig. 2A), the interaction between the two transcription factors is
determined using cytoplasmic extracts. Besides an EMSA analysis with
supershift detected after transfer to a PVDFmembrane (Fig. 2C.), using
the combined ELISA andWestern blotmethod, a 65 kDa protein can be
isolated by a p38 protein anchor and identiﬁed as p65 using the
respective antibody (Fig. 2D).
In resting cells, phosphorylated IκB binds to p65 via one of its
nuclear location sequence, preventing p65 from transmigrating into
the nucleus [37]. Potential complex formation of MAPK p38 occurs
also at one of the 2 nuclear location sequences (NLS) of p65 [37]. This
sequence is otherwise regarded as essential for allowing p65 to enter
the nucleus, with mutation of a single amino acid residue already
abolishing its nuclear target function [37]. Thus, it could be expected
that after ET-1 stimulation rising p38 levels will replace IκB at the NLS
site of p65. As Fig. 1G shows by ELISA, IκB is found as a partner of p65.
6 h after ET-1 induction the highest degree of p38 binding and
replacement of IκB can be observed.
Using site-directed mutagenesis of both p65 NLS sites and
subsequent transformation of the mutated p65-expression plasmid
into HeLa cells, we found in the cytoplasm for p65 an induction of
NF-κB at about the intensity observed in ET-1 stimulated cells. How-
ever, only with a non-mutated NLS is it possible to obtain a supershift
analysis with a speciﬁc, phosphorylated p38 antibody (Fig. 1E). This
raises the question, how this complex is moving into the nucleus, sincethe data suggest that p38 may occupy the NLS of p65, known to be an
important import signal [38]. However, other, and less well char-
acterized signals [39] are suspected, which could be facilitating this
transport, provided respective binding sites become known and
would be present in the proteins involved in this complex.
Since ET-1 stimulation involves the formation of a p65–p38
transcription complex, a modiﬁcation of target gene expression
could be expected, if either transcription factor is blocked. From the
literature the activation of the p38 pathway plays essential roles in the
production of pro-inﬂammatory cytokines (IL-8, TNFα, and IL-6) [40];
induction of enzymes such as COX-2 which controls connective tissue
remodelling in pathological conditions [41]; expression of intracel-
lular enzymes such as iNOS, a regulator of oxidation [42,43]; and
induction of VCAM-1 and other adherent proteins. By PCR in Fig. 1G,
we demonstrate that several NF-κB target genes are induced by ET-1.
This effect can be mimicked by a transfection of a p65 or a p38
expression plasmid (Fig. 2E). However, mutating the NLS of p65
reduces gene expression to its constitutive level in non-stimulated
HeLa cells.
Thus, the experiments demonstrate that p38 in ET-1 mediated
signalling is an essential partner of p65 in the formation of complex in
the cytoplasm. Modifying its binding or its expression level greatly
impedes on the intensity of NF-κB complex formation and its nuclear
migration. These results indicate a potential for therapeutic interven-
tion using mediators of p38 expression.
While these experiments demonstrate the formation of a p38–p65
complex already in the cytoplasm and also detectable in the nucleus,
other proteins are potentially part of this complex formation. Thus,
using an immunoprecipitationwith a p38 speciﬁc agarose-conjugated
antibody, one ﬁnds besides the expected components like p65 and
phosphorylated p38 isoforms such as alpha and beta, smaller amounts
of p50 and non-phosphorylated p38 beta (Fig. 3A,B). Importantly, no
IκBα is detected. In contrast, immunoprecipitation with untreated
extracts show low levels of IκBα.
Since the importins have been described as a major transport
mechanism into the nucleus [38], aWestern blot analysis with speciﬁc
antibodies to different importins is performed, which reveals the
importin alpha subunit 5 but not 4 as part of the immunoprecipitated,
stimulated extract. The importins are supposed to bind to the NLS of
the import substrate in the cytoplasm [38]. Since the NLS of p65 may
be interacting with p38, it is currently unclear how a member of the
importin family can itself attach to the complex. The immunopreci-
pitationwith the p38-AC antibody proves however, that this is indeed
the case.
From the present investigation, one can conclude that a p38–p65
complex with small amounts of p50 attached may be guided to the
nucleus using the importin alpha 5. The additional proteins besides
p38 and p65 may only comprise a very small portion of the complex
such as less than 10%, as is suggested by the EMSA analysis in Fig. 5A
after ET-1 induction. The question, how these proteins are attached to
each other, however, requires further studies including the crystal
structure of the complex, to fully elucidate the binding of the different
proteins with each other as well as the exact composition of the
complex and its three-dimensional arrangement.
Up to now, NF-κB signal transduction studies are rare [44], while
possible interactionwith other transcription factors such asMAPK p38
have not yet been published. The current concept from the literature
states that NF-κB is phosphorylated by MAPK p38 in tumor cells
[44,45]. The question arises, whether the role of p38 in the ET-1
induced complex formation is unique for HeLa cells. Thus, we analysed
several tumor cell lines, for which ET-1 is known as a potent mitogen,
and for which ET receptors had been reported at their cell surface,
including the ones used by Kuphal et al. [29]. From the literature,
MCF7 [46], Caki-1 [47], and HeLa cells are stimulated via the ET-A
receptor, while some melanoma cell lines are only activated via the
ET-B receptor [29]. In Fig. 5, in all tumor lines investigated by EMSA
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TC can be clearly shown, indicating that complex formation between
p65 and p38 is a widespread biologic event in ET-1 signaling.
The last set of experiments was performed to understand whether
the participation of p38 in the TC was a unique feature for ET-1
stimulation or not. To that end, we compared the analysis of TC by
supershift analyses for p65 and p38 with speciﬁc, phosphorylated
antibodies after 6 h of stimulation for ET-1 versus TNFα, a known
potent inducer of the NF-κB. After TNFα stimulation p38 was also a
partner for p65 (Fig. 5C). However, calculating the amount of p65
versus p38 found in the TC between the two mediators revealed a
signiﬁcant difference by densitometry. According to these results,
TNFα is a strong p65 inducer with its TC consisting of 2/3 of p65 and
only 1/3 of p38 (Fig. 5C). In contrast, ET-1 is a much weaker p65
inducer displaying almost exactly the reverse amounts for p65 and
p38 than TNFα (Fig. 5A). The remaining 9% of the unknown
component of the TC after TNFα has yet to be deﬁned; however by
gene expression analysis its importance for the TC function appears
negligible. As expected, the composition of the TC in ET-1 has a
signiﬁcant effect for the level of gene expression: an induction of all
target genes is signiﬁcantly reduced by blocking p38 (Fig. 5B). For
TNFα, the effect is much less pronounced. Still, for gene expression of
IL-6 and ET-1, p38 is needed to provide the maximally possible level of
gene expression (Fig. 5D). This result is in good agreement with
previous reports on the cooperative role of p38 for IL-6 induction [23].
To support this observation, an ELISA analysis of the components of
the TC after ET-1 or TNFα stimulationwas performed, conﬁrming that
the TC after ET-1 stimulation contains about twice the amount of p38
than after TNFα stimulation (Fig. 5E). In other cell lines (COS-1) a TNFα
induced p38 opposes the activation of NF-κB [48], necessitating future
studies. The actual composition of the p65/p38 complex induced by
ET-1 versus TNFα needs to be analysed further by proteomic means.
In summary, the present paper reveals a new role for p38 as an
important partner for p65 forming a complex in the cytoplasm and
migrating as complex associated with importin 5 into the nucleus.
This observation is found in several tumor cells lines, making it of
importance for therapeutic considerations. In addition, even strong
mediators of p65 as TNFα contain p38 in their TC, which is important
for some but not all induced genes.
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